Prosecution Insights
Last updated: July 17, 2026
Application No. 18/823,202

TISSUE SPECIMEN RETRIEVAL BAG, METHOD FOR RETRIEVING TISSUE

Non-Final OA §102§DP
Filed
Sep 03, 2024
Priority
Jun 10, 2009 — provisional 61/185,821 +5 more
Examiner
TOWNSEND, GUY K
Art Unit
Tech Center
Assignee
ConMed Corporation
OA Round
1 (Non-Final)
74%
Grant Probability
Favorable
1-2
OA Rounds
1y 2m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
533 granted / 719 resolved
+14.1% vs TC avg
Strong +26% interview lift
Without
With
+25.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
21 currently pending
Career history
728
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
74.5%
+34.5% vs TC avg
§102
7.8%
-32.2% vs TC avg
§112
0.8%
-39.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 719 resolved cases

Office Action

§102 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of the Claims Claim 1 is pending in the application. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (b) the invention was patented or described in a printed publication in this or a foreign country or in public use or on sale in this country, more than one year prior to the date of application for patent in the United States. Claim 1 is rejected under 35 U.S.C. 102(b) as being anticipated by Leroy (US 7955292 B2). PNG media_image1.png 499 582 media_image1.png Greyscale As to independent claim 1, Leroy teaches a tissue retrieval bag 10 [tissue extraction bag 10 Fig.1 Col.5,ll.44-67]; the bag comprising: a region of the bag (upper portion Fig.1) defining an opening 24 Fig.1 [porthole 24; Fig.1 annotated above; Col.5,ll.61] comprising at least one elongated portion extending along a first axis in a deployed position (elongated portion extending across opening along first axis as parallel to opening 24 in deployed position, e.g., between 52 and 30 in Fig.1 above); an exterior surface of the bag [top and outer surface of section 26] Fig.1 [Col.5,ll.59-60] depending from the opening 24 Fig.1; and a channel 32/42 Fig.1 [Col.6,ll.28-34] formed into the exterior surface of the bag [top and outer surface of section 26 Fig.1], wherein the channel 32/42 provides access to the interior of the bag through the exterior surface Fig.1 [Col.6,ll.28-34]. Non Statutory Obviousness Type Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP §§ 706.02(l)(1) - 706.02(l)(3) for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to: www.uspto.gov/patents/process/file/efs/guidance/eTD-info-I.jsp. Claim 1 is rejected on the ground of nonstatutory double patenting over claim 1 of US Patent No. 12,075,994 B2 (‘994) (issued from parent application 18/146056). As to claim 1, claim 1 of ‘994 teach or suggest the claimed tissue retrieval bag, as follows: Clm 1 ‘994 1 The differences between present claims and the claims of ‘994 claims do not identically recite each element of current claims (e.g., using substantially similar but not identical terms; different elements are in different claims; and/or different combinations of elements). However, the ‘994 claims teach or suggest each element of the current claims, as listed above, such that the present claims would have been obvious over the ‘994 claims to one of ordinary skill in the art at the time of the present invention. A two-way test is not to be applied in the present cases as Applicant could have filed the claims in a single application and there was no administrative delay. In re Berg, 46 USPQ2d 1226 (Fed. Cir. 1998) (“The two-way exception can only apply when the applicant could not avoid separate filings, and even then, only if the PTO controlled the rates of prosecution to cause the later filed species claims to issue before the claims for a genus in an earlier application . . . In Berg’s case, the two applications could have been filed as one, so it is irrelevant to our disposition who actually controlled the respective rates of prosecution.”). In the absence of administrative delay, a one-way test is appropriate. In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993). Unless the record clearly shows administrative delay by the Office and that applicant could not have avoided filing separate applications, the examiner may use the one-way obviousness determination and shift the burden to applicant to show why a two-way obviousness determination is required. One would be motivated to provide each element of the present claims from the ‘994 claims, as they both relate to the same type of device with the same elements for the same purpose and function in the same field of endeavor. Claim 1 is rejected on the ground of nonstatutory double patenting over claim 1 of US Patent No. 11,540,818 B2 (‘818). As to claim 1, claim 1 of ‘818 teach or suggest the claimed tissue retrieval bag, as follows: Clm 1 ‘818 1 The differences between present claims and the claims of ‘818 claims do not identically recite each element of current claims (e.g., using substantially similar but not identical terms; different elements are in different claims; and/or different combinations of elements). However, the ‘818 claims teach or suggest each element of the current claims, as listed above, such that the present claims would have been obvious over the ‘818 claims to one of ordinary skill in the art at the time of the present invention. A two-way test is not to be applied in the present cases as Applicant could have filed the claims in a single application and there was no administrative delay. In re Berg, 46 USPQ2d 1226 (Fed. Cir. 1998) (“The two-way exception can only apply when the applicant could not avoid separate filings, and even then, only if the PTO controlled the rates of prosecution to cause the later filed species claims to issue before the claims for a genus in an earlier application . . . In Berg’s case, the two applications could have been filed as one, so it is irrelevant to our disposition who actually controlled the respective rates of prosecution.”). In the absence of administrative delay, a one-way test is appropriate. In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993). Unless the record clearly shows administrative delay by the Office and that applicant could not have avoided filing separate applications, the examiner may use the one-way obviousness determination and shift the burden to applicant to show why a two-way obviousness determination is required. One would be motivated to provide each element of the present claims from the ‘818 claims, as they both relate to the same type of device with the same elements for the same purpose and function in the same field of endeavor. Claim 1 is rejected on the ground of nonstatutory double patenting over claim 1 of US Patent No. 9,974,528 B2 (‘528). As to claim 1, claim 1 of ‘528 teach or suggest the claimed tissue retrieval bag, as follows: Claim 1 ‘528 1 The differences between present claims and the claims of ‘528 claims do not identically recite each element of current claims (e.g., using substantially similar but not identical terms; different elements are in different claims; and/or different combinations of elements). However, the ‘528 claims teach or suggest each element of the current claims, as listed above, such that the present claims would have been obvious over the ‘528 claims to one of ordinary skill in the art at the time of the present invention. A two-way test is not to be applied in the present cases as Applicant could have filed the claims in a single application and there was no administrative delay. In re Berg, 46 USPQ2d 1226 (Fed. Cir. 1998) (“The two-way exception can only apply when the applicant could not avoid separate filings, and even then, only if the PTO controlled the rates of prosecution to cause the later filed species claims to issue before the claims for a genus in an earlier application . . . In Berg’s case, the two applications could have been filed as one, so it is irrelevant to our disposition who actually controlled the respective rates of prosecution.”). In the absence of administrative delay, a one-way test is appropriate. In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993). Unless the record clearly shows administrative delay by the Office and that applicant could not have avoided filing separate applications, the examiner may use the one-way obviousness determination and shift the burden to applicant to show why a two-way obviousness determination is required. One would be motivated to provide each element of the present claims from the ‘528 claims, as they both relate to the same type of device with the same elements for the same purpose and function in the same field of endeavor. Conclusion The prior art made of record and not relied upon, as listed in the attached PTO Form 892, is considered relevant to Applicants’ disclosure and are cited to show the general state of the art, e.g., Spaeth (US 5354303 A) (Figs.1,10-11; Col.5,7); Taylor (US 2008/0234696 A1) ([0058]-[0069]); and Taylor (US 2010/0318045 A1) (Fig.1 [0024-0027]; [0038]. Any inquiry concerning this communication or earlier communications from the examiner should be directed to GUY K. TOWNSEND whose telephone number is (571) 270-3689. The examiner can normally be reached Mon. - Fri., 8 am to 5 pm. The direct fax number is (571) 270-4689. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, REBECCA EISENBERG, can be reached on 571-270-5879. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /GUY K TOWNSEND/Primary Examiner, Art Unit 3781
Read full office action

Prosecution Timeline

Sep 03, 2024
Application Filed
Jun 23, 2026
Non-Final Rejection mailed — §102, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678532
ABSORBENT ARTICLE COMPRISING A LUBRICANT AGENT
4y 1m to grant Granted Jul 14, 2026
Patent 12672977
Monitor device with human-readable identifier
3y 9m to grant Granted Jul 07, 2026
Patent 12672978
MENSTRUAL RECEPTACLE APPLICATOR AND METHOD OF INSERTING A MENSTRUAL RECEPTACLE
3y 10m to grant Granted Jul 07, 2026
Patent 12672979
Combined Pessary and Menstrual Cup
2y 10m to grant Granted Jul 07, 2026
Patent 12673150
MULTI-POSITION MODULAR CARBON DIOXIDE DETECTOR AND INDICATOR AND METHODS OF USE
2y 5m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
74%
Grant Probability
99%
With Interview (+25.6%)
3y 0m (~1y 2m remaining)
Median Time to Grant
Low
PTA Risk
Based on 719 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month